Murtaza Mussaji v. HHS ( 2018 )


Menu:
  •      Case: 17-60694      Document: 00514566482         Page: 1    Date Filed: 07/23/2018
    IN THE UNITED STATES COURT OF APPEALS
    FOR THE FIFTH CIRCUIT
    United States Court of Appeals
    Fifth Circuit
    FILED
    No. 17-60694                                July 23, 2018
    Summary Calendar                             Lyle W. Cayce
    Clerk
    MURTAZA MUSSAJI, D.O., P.A., doing business as Fairway Medical Clinic,
    doing business as Shadow Creek Medical Clinic,
    Petitioner
    v.
    UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES,
    Respondent
    Petition for Review of a Decision of the United States
    Department of Health and Human Services,
    Departmental Appeals Board,
    Decision No. 2811
    HHS Nos. A-17-48 & A-17-49
    Before KING, ELROD, and HIGGINSON, Circuit Judges.
    STEPHEN A. HIGGINSON, Circuit Judge:*
    The United States Department of Health and Human Services
    Departmental Appeals Board dismissed Murtaza Mussaji’s request for a
    hearing to challenge revocation of two laboratory certificates issued pursuant
    * Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not
    be published and is not precedent except under the limited circumstances set forth in 5TH
    CIR. R. 47.5.4.
    Case: 17-60694    Document: 00514566482     Page: 2    Date Filed: 07/23/2018
    No. 17-60694
    to the Clinical Laboratories Improvements Act of 1988. Mussaji now petitions
    our court for review of the Board’s decision. The petition is denied.
    I.
    The Clinical Laboratories Improvements Act of 1988 (CLIA) regulates
    labs that conduct diagnostic tests on human specimens. 42 U.S.C. § 263a. The
    law requires that such labs obtain a certificate from the U.S. Department of
    Health and Human Services (HHS). 
    Id. § 263a(b).
    Certified labs must conform
    to regulations promulgated by HHS, and HHS is authorized to inspect labs to
    ensure compliance. 
    Id. §§ 263a(c)(1),
    (g). If HHS discovers that a lab no longer
    meets HHS’s certification requirements, the agency may impose sanctions
    including revocation of the certificate. 
    Id. § 263a(i).
    Before revoking a
    certificate, HHS must provide the lab owner or operator “reasonable notice and
    opportunity for hearing.” 
    Id. Under CLIA’s
    implementing regulations, the Centers for Medicare and
    Medicaid Services (CMS), a division of HHS, gives notice to laboratories when
    it makes an initial determination to revoke a CLIA certificate. 42 C.F.R. §
    493.1844(g)(1). A lab “has 60 days from the notice of sanction to request a
    hearing” before an Administrative Law Judge (ALJ). 
    Id. § 493.1844(f)(1);
    see
    also 
    id. § 498.40(a)(2)
    (“The affected party or its legal representative or other
    authorized official must file the [hearing] request in writing within 60 days
    from receipt of the notice of initial, reconsidered, or revised determination
    unless that period is extended . . . .”). The ALJ may extend the 60-day period
    “[f]or good cause shown.” 
    Id. § 498.40(c)(2).
          Murtaza Mussaji operated two CLIA certified labs, Shadow Creek
    Medical Clinic and Fairway Medical Clinic. On January 29, 2015, the Texas
    Department of State Health Services notified Mussaji that a recent inspection
    had revealed that Shadow Creek was not in compliance with CLIA
    requirements. The letter further asserted that Shadow Creek’s “deficient
    2
    Case: 17-60694   Document: 00514566482     Page: 3    Date Filed: 07/23/2018
    No. 17-60694
    practices . . . pose[d] immediate jeopardy to patient health and safety.” The
    letter stated that if Shadow Creek did not come into compliance, the case would
    be referred to CMS.
    CMS faxed Mussaji a letter on July 8, 2015. The letter stated that
    Shadow Creek’s CLIA certificate would be revoked if, among other things,
    Shadow Creek did not request a hearing by September 8, 2015. CMS faxed
    Mussaji a similar letter regarding Fairway on January 12, 2016. This letter
    explained that operators of labs that have had a certificate revoked are
    prohibited from owning or operating any lab for two years. See 42 U.S.C. §
    263a(i)(3). Therefore, because Shadow Creek’s certificate had been revoked,
    Fairway’s certificate would be revoked as well. Mussaji denies receiving either
    fax.
    The parties agree, however, that Mussaji received several other related
    letters from CMS. In an April 8, 2015 letter to Shadow Creek, CMS stated:
    “Your laboratory’s CLIA certificate will be revoked effective June 9, 2015, if
    one or all of the following occurs: . . . a request for a hearing is not received by
    June 9, 2015.” (emphasis omitted). Mussaji responded to this letter, and sent
    CMS back a plan to correct Shadow Creek’s deficiencies.
    On September 23, 2015, CMS faxed Mussaji a letter informing him that
    Shadow Creek’s CLIA certificate had been revoked due to, among other things,
    Mussaji’s failure to file an appeal by September 8, 2015. Mussaji acknowledged
    receiving this fax in an email dated September 29 2015, and again in a letter
    to CMS dated October 20, 2015.
    On October 30, 2015, CMS sent Mussaji a letter reiterating that Shadow
    Creek’s CLIA certificate had been revoked and that the appeal deadline of
    September 8, 2015 had passed. Mussaji responded to this letter and
    acknowledged receiving it.
    3
    Case: 17-60694     Document: 00514566482      Page: 4   Date Filed: 07/23/2018
    No. 17-60694
    On April 5, 2016, CMS sent Mussaji a letter stating that Fairway’s CLIA
    certificate had been revoked. The letter referenced the January 12, 2016 letter
    and explained that Fairway’s deadline for appealing the revocation passed on
    March 14, 2016. Mussaji again responded and acknowledged receiving CMS’s
    letter.
    On October 14, 2016—more than eighteen months after the first letter
    Mussaji acknowledged and more than six months after the last—Mussaji
    requested a hearing before an ALJ for both Shadow Creek and Fairway. The
    ALJ found that Mussaji had actual knowledge that both certificates had been
    revoked more than 60 days before he sought review, and held that his hearing
    requests were therefore untimely. The ALJ further found that Mussaji failed
    to show good cause for the delay and dismissed the request for a hearing.
    HHS’s Departmental Appeals Board sustained the ALJ’s ruling, and Mussaji
    now petitions this court for review.
    II.
    CLIA gives this court “jurisdiction to affirm . . . , or to set . . . aside in
    whole or in part, temporarily or permanently” HHS’s decision to suspend a
    laboratory’s certificate. 42 U.S.C. § 263a(k)(3). HHS’s factual findings are
    conclusive “if supported by substantial evidence.” 
    Id. The ALJs
    finding that Mussaji had actual notice that Shadow Creek and
    Fairway’s certificates had been revoked months before he requested a hearing
    is supported by substantial evidence. As detailed above, Mussaji repeatedly
    acknowledged receipt of various letters from CMS explaining that his CLIA
    certificates had been revoked.
    Mussaji argues however that CMS was required to send him notice by
    U.S. mail, and the agency’s failure to do so rendered notice ineffective. He cites
    42 C.F.R. § 498.20(a)(1), which states that, as a “[g]eneral rule” CMS “mails
    4
    Case: 17-60694    Document: 00514566482     Page: 5   Date Filed: 07/23/2018
    No. 17-60694
    notice of an initial determination to the affected party.” (emphasis added).
    HHS disputes whether § 498.20(a)(1) applies, and argues that, even if it does,
    faxing Mussaji notice satisfied the regulation. HHS further argues that, even
    assuming it was required to send notice by U.S. mail, its procedural error was
    rendered harmless by Mussaji’s actual knowledge of the revocations.
    “‘Procedural perfection in administrative proceedings is not required’ as
    long as ‘the substantial rights of a party have not been affected.’” Audler v.
    Astrue, 
    501 F.3d 446
    , 448 (5th Cir. 2007) (quoting Mays v. Bowen, 
    837 F.2d 1362
    , 1364 (5th Cir. 1988)). Accordingly, this court will not set aside agency
    action for mere harmless error. See, e.g, Graves v. Colvin, 
    837 F.3d 589
    , 592–
    93 (5th Cir. 2016).
    In Shinseki v. Sanders, the Supreme Court held that an agency’s notice
    error was harmless where petitioner “ha[d] not explained . . . how the notice
    error to which he point[ed] could have made any difference.” 
    556 U.S. 396
    , 413
    (2009); see also Gov’t of Canal Zone v. Brooks, 
    427 F.2d 346
    , 348 (5th Cir. 1970)
    (government agency’s noncompliance with own notice regulation was de
    minimis error). Similarly here, given the ALJ’s finding that Mussaji waited
    more than a year after first learning of the revocations to seek review, Mussaji
    makes no showing that receiving notice by U.S. mail made any difference.
    Therefore, even assuming that the relevant regulations require notice by U.S.
    mail, which we do not decide today, CMS’s error in faxing the notice was
    harmless. Similarly, given Mussaji’s actual knowledge of the revocation, the
    ALJ’s finding that Mussaji failed to show good cause for his delay is supported
    by substantial evidence.
    III.
    The petition for review is DENIED.
    5